Skriftligt spörsmål om de minskade ersättningarna för diabetesläkemedel

This question concerns the reduction in reimbursements for diabetes medications. It highlights the potential impact on patients and the healthcare system, particularly regarding co-payments and associated illnesses. The question seeks clarification on the reasons behind these reduced reimbursements and their implications for individuals managing diabetes and other related health conditions.